Lawlis V Bryan Insider Trades

Insider Trading History

Track insider trading activity for Lawlis V Bryan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Geron
Geron GERN
Director
Holding Value $218k 180,000 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 180,000 shares
$1.34
$1.21
Geron
Geron GERN
Director
Holding Value $16.1k 13,300 shares
Last Trade
May 09, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.7k 13,300 shares
$1.18
$1.21
Geron
Geron GERN
Director
Holding Value $0 0 shares
Last Trade
May 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$131k 35,000 shares
$3.75
$1.21
Geron
Geron GERN
Director
Holding Value $42.4k 35,000 shares
Last Trade
May 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$137k 35,000 shares
$3.90
$1.21
Geron
Geron GERN
Director
Holding Value $0 0 shares
Last Trade
May 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$137k 35,000 shares
$3.90
$1.21
Geron
Geron GERN
Director
Holding Value $218k 180,000 shares
Last Trade
May 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$698k 180,000 shares
$3.88
$1.21
Geron
Geron GERN
Director
Holding Value $151k 125,000 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$409k 125,000 shares
$3.27
$1.21
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $1.87M 33,140 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 4,190 shares
$91.99
$56.47
Geron
Geron GERN
Director
Holding Value $0 0 shares
Last Trade
May 11, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$105k 35,000 shares
$3.00
$1.21
Geron
Geron GERN
Director
Holding Value $42.4k 35,000 shares
Last Trade
May 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 35,000 shares
$2.89
$1.21
Geron
Geron GERN
Director
Holding Value $0 0 shares
Last Trade
May 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 35,000 shares
$2.89
$1.21
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $0 0 shares
Last Trade
Apr 03, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$821k 8,500 shares
$96.60
$56.47
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $2.11M 37,450 shares
Last Trade
Apr 03, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$821k 8,500 shares
$96.60
$56.47
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $1.63M 28,950 shares
Last Trade
Apr 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$825k 8,500 shares
$97.09
$56.47
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $3.37M 43,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$78.48
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $516k 43,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$785k 43,000 shares
$18.25
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $516k 43,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$785k 43,000 shares
$18.25
$12.01
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $1.63M 28,950 shares
Last Trade
May 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$392k 4,980 shares
$78.78
$56.47
Geron
Geron GERN
Director
Holding Value $151k 125,000 shares
Last Trade
May 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 125,000 shares
$1.48
$1.21
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $1.59M 28,220 shares
Last Trade
Apr 14, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$353k 4,250 shares
$82.95
$56.47

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up